Literature DB >> 15198141

Outcome of apparent ureteropelvic junction obstruction identified by investigation of fetal hydronephrosis.

Guilherme T Apocalypse1, Eduardo A Oliveira, Eli A S Rabelo, José S S Diniz, Viviane S P Marino, Alamanda K Pereira, Carlos J R Simal, Luciana P L Gazolla, Tiago A Fagundes.   

Abstract

OBJECTIVES: The purpose of the study was to evaluate the outcome of prenatally detected ureteropelvic junction obstruction (UPJO) managed with a more conservative protocol.
METHODS: The records and imaging studies of 77 consecutive neonates with UPJO identified by fetal hydronephrosis were reviewed. A nonoperative approach was attempted in patients with mild/moderate pelvic dilatation, renal units with good function as ascertained by DMSA scan and a non-obstructed pattern on DTPA. Otherwise, the patients were managed surgically by pyeloplasty. Both groups were prospectively followed and the imaging studies were performed before and after the initial approach and at one-year intervals thereafter.
RESULTS: Of the 77 infants (85 units), 39 were submitted to surgery (33 pyeloplasty and 7 nephrectomy) and 38 were conservatively managed. During follow-up, 9 (24%) of 38 patients in the non-operative group presented renal function deterioration and 3 presented with urinary infections and were submitted to pyeloplasty. Of the 39 patients surgically managed, 76% presented improvement of hydronephrosis and 90% showed a non-obstructed pattern on diuretic renography. The differential renal uptake, as measured by DMSA scan, remained stable in the three groups analyzed (conservative, initial pyeloplasty, and delayed pyeloplasty). There was a minimal improvement in those units submitted to pyeloplasty with impaired renal function at baseline (< 40%). Mean renal uptake was 28.6% at admission and 33.9% at the end of follow-up.
CONCLUSION: There was a wide spectrum of ureteropelvic junction stenosis. Surgical intervention in a subgroup of patients with severe hydronephrosis and impaired function may possibly improve or preserve renal parenchyma. Conversely, conservative management and clinical follow-up are safe and desirable for the subgroup with mild/moderate pelvic dilatation and preserved renal function.

Entities:  

Mesh:

Year:  2003        PMID: 15198141     DOI: 10.1023/b:urol.0000025621.93025.3d

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  26 in total

Review 1.  Recoverability of renal function after relief of chronic partial upper urinary tract obstruction.

Authors:  A A Shokeir; A P Provoost; R J Nijman
Journal:  BJU Int       Date:  1999-01       Impact factor: 5.588

2.  Salvage pyeloplasty in nonvisualizing hydronephrotic kidney secondary to ureteropelvic junction obstruction.

Authors:  I E Bassiouny
Journal:  J Urol       Date:  1992-08       Impact factor: 7.450

3.  Prenatally diagnosed hydronephrosis: the Great Ormond Street experience.

Authors:  H K Dhillon
Journal:  Br J Urol       Date:  1998-04

4.  Surgery versus observation for managing obstructive grade 3 to 4 unilateral hydronephrosis: a report from the Society for Fetal Urology.

Authors:  L S Palmer; M Maizels; P C Cartwright; S K Fernbach; J J Conway
Journal:  J Urol       Date:  1998-01       Impact factor: 7.450

5.  Quantitative SPECT of 99mTc-DMSA uptake in kidneys of infants with unilateral ureteropelvic junction obstruction: assessment of structural and functional abnormalities.

Authors:  D Groshar; M Wald; B Moskovitz; E Issaq; O Nativ
Journal:  J Nucl Med       Date:  1999-07       Impact factor: 10.057

6.  Antenatally detected pelvi-ureteric junction obstruction: concerns about conservative management.

Authors:  R Subramaniam; C Kouriefs; A P Dickson
Journal:  BJU Int       Date:  1999-08       Impact factor: 5.588

7.  Prognostic factors in fetal hydronephrosis: a multivariate analysis.

Authors:  E A Oliveira; J S Diniz; A C Cabral; H V Leite; E A Colosimo; R B Oliveira; A S Vilasboas
Journal:  Pediatr Nephrol       Date:  1999-11       Impact factor: 3.714

8.  Clinical outcome and follow-up of prenatal hydronephrosis.

Authors:  A Blachar; Y Blachar; P M Livne; L Zurkowski; D Pelet; B Mogilner
Journal:  Pediatr Nephrol       Date:  1994-02       Impact factor: 3.714

Review 9.  Neonatal hydronephrosis--the controversy and the management.

Authors:  B M Tripp; Y L Homsy
Journal:  Pediatr Nephrol       Date:  1995-08       Impact factor: 3.714

10.  Urinary tract anomalies detected by prenatal ultrasound examination at Mayo Clinic Rochester.

Authors:  J M Gloor; P L Ogburn; R J Breckle; B Z Morgenstern; D S Milliner
Journal:  Mayo Clin Proc       Date:  1995-06       Impact factor: 7.616

View more
  3 in total

Review 1.  Is it always necessary to treat a ureteropelvic junction syndrome?

Authors:  Paul J Van Cangh
Journal:  Curr Urol Rep       Date:  2007-03       Impact factor: 3.092

2.  Probability of urinary tract infection in infants with ureteropelvic junction obstruction: is antibacterial prophylaxis really needed?

Authors:  Ali Islek; Ayfer Gür Güven; Mustafa Koyun; Sema Akman; Emel Alimoglu
Journal:  Pediatr Nephrol       Date:  2011-04-26       Impact factor: 3.714

3.  Hydronephrosis in infants and children: natural history and risk factors for persistence in children followed by a medical service.

Authors:  Kristy Vandervoort; Stephanie Lasky; Christine Sethna; Rachel Frank; Suzanne Vento; Jeanne Choi-Rosen; Beatrice Goilav; Howard Trachtman
Journal:  Clin Med Pediatr       Date:  2009-12-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.